Management of a case of neuroleptic malignant syndrome with bromocriptine
- 1 December 1983
- journal article
- case report
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 140 (12) , 1619-1620
- https://doi.org/10.1176/ajp.140.12.1619
Abstract
Neuroleptic malignant syndrome, a rare but potentially fatal side effect of antipsychotic medications, has often proven refractory to conventional antiparkinsonian medications. The authors report a dramatic response of this syndrome to the dopamine agonist bromocriptine mesylate in a patient receiving fluphenazine decanoate.Keywords
This publication has 0 references indexed in Scilit: